ENDRA Life Sciences Inc.
NDRA
$3.86
$0.29188.19%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -22.93% | -11.78% | -12.31% | -16.45% | -4.74% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -35.54% | -24.21% | -21.75% | -20.04% | -4.18% |
| Operating Income | 35.54% | 24.21% | 21.75% | 20.04% | 4.18% |
| Income Before Tax | 25.83% | 21.79% | 25.41% | 23.67% | 8.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.83% | 21.79% | 25.41% | 23.67% | 8.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.83% | 21.79% | 25.41% | 23.67% | 8.50% |
| EBIT | 35.54% | 24.21% | 21.75% | 20.04% | 4.18% |
| EBITDA | 35.30% | 24.07% | 21.88% | 20.40% | 4.58% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
